The Europe Plasma Fractionation Market is expected to grow from US$ 6,824.67 million in 2021 to US$ 10,402.95 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. Increasing geriatric population, increasing use of immunoglobulins in various therapeutic areas such as neurology, hematology, rare genetic disorders and autoimmune disorders along with growing demand for plasma derived therapies for management of diseases are all expected to boost plasma fractionation market in rest of Europe. Furthermore, various companies in Europe are investing more on research and development activities to develop and launch novel approaches in plasma therapies for management of diseases.
Europe Plasma Fractionation Market Overview
The Europe plasma fractionation market encompasses key countries such as Germany, France, the UK, Spain, Italy, and the rest of Europe. Holding a substantial share in the global plasma fractionation industry, the region is projected to experience strong growth in the coming years. This expansion is driven by several factors, including an aging population, rising demand for immunoglobulins in treating chronic diseases, increasing prevalence of immune and bleeding disorders, and the growing adoption of plasma-based therapies for disease management.
Market Dynamics and COVID-19 Impact
The medical landscape in Europe has evolved significantly, particularly in the treatment of chronic conditions such as neurological, hematological, and respiratory diseases. The COVID-19 pandemic further influenced healthcare priorities, with medical professionals focusing on critical care and pandemic response. Many research institutions shifted their efforts toward COVID-19 studies, accelerating the understanding of the virus and potential treatments.
Plasma therapy emerged as a key therapeutic approach during the pandemic. Regulatory bodies such as France’s National Agency for Medicines and Health Products Safety (ANSM) endorsed immune plasma therapy for critically ill patients, while the European Commission recommended convalescent plasma as an emergency treatment. These developments provided a temporary boost to the plasma fractionation market.
However, the pandemic also disrupted standard treatment protocols for other diseases, as pharmaceutical companies prioritized COVID-19-related research. This shift temporarily hindered market growth for non-pandemic-related plasma therapies.
Europe Plasma Fractionation Market Segmentation
Europe Plasma Fractionation Market -By Product
- Immunoglobulin
- Intravenous Immunoglobulin (IVIG)
- Subcutaneous Immunoglobulin (SCIG)
- Albumin
- Coagulation Factor Concentrates
- Protease Inhibitors
- Other
Europe Plasma Fractionation Market – By Application
- Neurology
- Immunology
- Hematology
- Critical Care
- Pulmonology
- Others
Europe Plasma Fractionation Market – By End User
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Europe Plasma Fractionation Market – By Country
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Europe Plasma Fractionation Market – Company Profiles
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- Sanquin
- SK Plasma
Strategic Insights for Market Success
To navigate the evolving Europe plasma fractionation market, stakeholders must leverage data-driven insights to identify growth opportunities and competitive advantages. Key strategic considerations include:
- Market Trends & Opportunities: Analyzing current and emerging trends to uncover unmet needs in plasma-derived therapies, such as expanding applications in immunology and rare diseases.
- Competitive Landscape: Assessing key players, market positioning, and innovation strategies to differentiate offerings.
- Regional Variations: Understanding country-specific regulatory frameworks, healthcare policies, and demand patterns to optimize market entry and expansion.
- Future Outlook: Anticipating long-term shifts, including advancements in plasma collection, fractionation technologies, and personalized medicine approaches.
By adopting a forward-thinking approach, industry participants—whether manufacturers, investors, or healthcare providers—can make informed decisions to enhance profitability and sustain growth in this dynamic market. Strategic insights empower stakeholders to capitalize on emerging opportunities, mitigate risks, and secure a competitive edge in Europe’s evolving plasma fractionation industry.
Other Reports:
Europe Aramid Fiber Market: https://business-news-insights.blogspot.com/2025/04/europe-aramid-fiber-market-future.html
North America Medical Marijuana Market: https://sites.google.com/view/northamericamedicalmarijuanama/home
North America Wound Care Market: https://www.quora.com/profile/Business-Market-Insights/North-America-Wound-Care-Market-Trends-Competitive-Landscape-Size-Segments-2028-Get-Full-Report-North-America-Wound
North America Biosimilars Market: https://penzu.com/p/00a466559699bffc
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
